HomeCompareRMD vs SHW

RMD vs SHW: Dividend Comparison 2026

RMD yields 1.06% · SHW yields 1.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHW wins by $277.6K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
SHW
SHW
● Live price
1.00%
Share price
$315.90
Annual div
$3.17
5Y div CAGR
76.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$309.3K
Annual income
$185,821.41
Full SHW calculator →

Portfolio growth — RMD vs SHW

📍 SHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDSHW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + SHW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
SHW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
SHW
Annual income on $10K today (after 15% tax)
$85.30/yr
After 10yr DRIP, annual income (after tax)
$157,948.20/yr
At 15% tax rate, SHW beats the other by $155,153.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + SHW for your $10,000?

RMD: 50%SHW: 50%
100% SHW50/50100% RMD
Portfolio after 10yr
$170.5K
Annual income
$94,554.82/yr
Blended yield
55.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SHW right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
SHW
Analyst Ratings
24
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$396.83
+25.6% upside vs current
Range: $371.00 — $420.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
SHW buys
14
PoliticianChamberTickerTypeAmountDate
Jared Moskowitz🏢 House$SHW▼ Sell$15,001 - $50,0002025-10-10
Jared Moskowitz🏢 House$SHW▼ Sell$1,001 - $15,0002025-10-10
Jared Moskowitz🏢 House$SHW▼ Sell$1,001 - $15,0002025-10-10
Ro Khanna🏢 House$SHW▼ Sell$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-08-26
Shelley Moore Capito🏛 Senate$SHW▲ Buy$1,001 - $15,0002025-08-01
Shelley Moore Capito🏛 Senate$SHW▲ Buy$1,001 - $15,0002025-08-01
Ro Khanna🏢 House$SHW▲ Buy$1,001 - $15,0002025-07-25
Valerie Hoyle🏢 House$SHW▼ Sell$1,001 - $15,0002025-07-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDSHW
Forward yield1.06%1.00%
Annual dividend / share$2.33$3.17
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%76.6%
Portfolio after 10y$31.7K$309.3K
Annual income after 10y$3,288.25$185,821.41
Total dividends collected$10.4K$277.6K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$295.88$396.83

Year-by-year: RMD vs SHW ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrSHW PortfolioSHW Income/yrGap
1← crossover$10,844$143.91$10,877$177.21$33.00SHW
2$11,801$198.21$11,957$318.14$156.00SHW
3$12,901$273.96$13,371$577.20$470.00SHW
4$14,185$380.39$15,372$1,065.33$1.2KSHW
5$15,709$531.20$18,470$2,021.46$2.8KSHW
6$17,556$747.16$23,771$4,008.63$6.2KSHW
7$19,845$1,060.53$33,950$8,515.19$14.1KSHW
8$22,757$1,522.63$56,399$20,072.16$33.6KSHW
9$26,567$2,217.64$115,381$55,033.62$88.8KSHW
10$31,715$3,288.25$309,279$185,821.41$277.6KSHW

RMD vs SHW: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

SHWMaterials

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors, and do-it-yourself homeowners. The Consumer Brands Group segment supplies a portfolio of branded and private-label architectural paints, stains, varnishes, industrial products, wood finishes products, wood preservatives, applicators, corrosion inhibitors, aerosols, caulks, and adhesives to retailers and distributors. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications, automotive refinish products, protective and marine coatings, coil coatings, packaging coatings, and performance-based resins and colorants. It serves retailers, dealers, jobbers, licensees, and other third-party distributors through its branches and direct sales staff, as well as through outside sales representatives. The company has operations primarily in the North and South America, the Caribbean, Europe, Asia, and Australia. As of February 17, 2022, it operated approximately 5,000 company-operated stores and facilities. The Sherwin-Williams Company was founded in 1866 and is headquartered in Cleveland, Ohio.

Full SHW Calculator →
📬

Get this RMD vs SHW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.